About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Addressing Unmet Needs in the Management of AML: From Testing to Targeted Therapy
Addressing Unmet Needs in the Management of AML: From Testing to Targeted Therapy
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
A
Emerging Treatment Options for AML in 2024
By
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
FEATURING
Alexander Perl
By
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
FEATURING
Alexander Perl
259 views
March 3, 2024
0 Comments
Login to view comments.
Click here to Login
Addressing Unmet Needs in the Management of AML: From Testing to Targeted Therapy
17:01
Indy Hematology Review
Current, Emerging, and Targeted Therapies for the Treatment of R/R A…
Feat.
R. Komrokji
17:51
Indy Hematology Review
Treatment of AML: Managing the Patient When Transplant Is Not an Opt…
Feat.
H. Erba
28:02
University of Colorado Division of Hematology
2024 Updates in AML
Feat.
C. McMahon
06:13
Insights from 2023 ASH Annual Meeting
QuANTUM-First Trial - PROs in FLT3-ITD Mutated AML Receiving Quizart…
Feat.
E. Oliva
29:38
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024
Advances in Frontline Treatment of FLT3-Mutated AML
Feat.
N. Short
07:56
University of Miami Sylvester Comprehensive Cancer Center
Role of Mutations in AML: FLT3-ITD Mutation Confers Poor Prognosis b…
Feat.
S. Venugopal
18:27
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "QuANTUM-First - Safety by Treatment Phase a…
Feat.
H. Erba
22:30
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient
Emerging Treatment Options for AML in 2024
Feat.
A. Perl
22:37
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "The Best of Acute Leukemia and MDS - Highlig…
Feat.
T. Badar
10:32
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Quizartinib, Venetoclax, & Decitabine T…
Feat.
M. Yilmaz
